Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Using brain stimulation to improve pain and function in knee tendon injuries

Official title: Effectiveness of Transcranial Direct Current Stimulation on Functionality and Pain in Individuals With Patellar Tendinopathy: Randomized Clinical Trial

Run by University of Valencia · NCT06729437 · Data updated 2026-11-12

This study is testing if a new brain stimulation technique combined with special exercises can help people with knee tendon injuries feel less pain and move better.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment42 (estimated)
SponsorUniversity of Valencia
Academic / other
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedJuly 1, 2027
Study endsJuly 1, 2027
Registry record updatedJune 25, 2026
Trial IDNCT06729437 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18 to 50 with a diagnosis of patellar tendinopathy and persistent pain lasting more than 3 months.

Probably not a fit

Patients with previous knee surgery, systemic inflammatory diseases, or contraindications for tDCS are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of transcranial direct current stimulation (tDCS) combined with a therapeutic eccentric exercise program for individuals suffering from patellar tendinopathy. Participants will be randomly assigned to either an experimental group receiving tDCS or a control group receiving sham stimulation, both undergoing an 8-week exercise program. Assessments will be conducted at baseline, week 4, week 8, and week 12 to evaluate pain, functionality, muscle activity, strength, proprioception, and quality of life. The goal is to enhance treatment adherence and clinical outcomes for this common and persistent knee condition.

Why it matters

Potential benefit: If successful, this approach could significantly reduce pain and improve functionality for patients with patellar tendinopathy.

How similar studies have gone: While the combination of tDCS with therapeutic exercise is an emerging approach, existing studies have shown promising results, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 50 years.
* Diagnosis of patellar tendinopathy (VISA-P score of 80 or lower).
* Pain lasting more than 3 months.

Exclusion Criteria:

* Previous knee surgery.
* Corticosteroid injection in the previous 6 weeks.
* Systemic inflammatory, autoimmune, or rheumatic diseases.
* Cognitive or behavioural issues that hinder comprehension and adherence to the intervention.
* Any neurological disease.
* Neoplastic disease.
* Subjects presenting contraindications for tDCS (Thair et al., 2017), including: personal and family history of epilepsy, metallic implants in the head, implanted medication pump, pacemaker, recurrent headaches, skin conditions (psoriasis, eczema), or major head surgeries, pregnancy, heart diseases, and various medications (psychotropic or antihistamines).
* Subjects must not have undergone pharmacological treatment or knee physical rehabilitation programs for a period of 1 year.

Where it's running

  • Faculty of Physiotherapy, University of Valencia
    Valencia, Valencia, Spain
    Recruiting

Study contacts

  • Principal investigator: Marta Inglés, Dr — Univeristy of Valencia
  • Study coordinator: Marta Inglés, Dr
  • Email: marta.ingles@uv.es
  • Phone: 963 98 38 55

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.